SCHEMBL26423640

SCHEMBL26423640

NC(=O)Cc1cccc(Cl)c1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 3/20 0.67
HTR3B O95264 3/20 0.67
HTR3A P46098 3/20 0.67
HTR3D Q70Z44 3/20 0.67
HTR3C Q8WXA8 3/20 0.67
CTBP2 P56545 1/20 0.59
PNMT P11086 1/20 0.55
PIK3CA P42336 1/20 0.54
KDM4E B2RXH2 1/20 0.53
KMT2A Q03164 2/20 0.53
MAPK8 P45983 1/20 0.52
TAAR1 Q96RJ0 2/20 0.52
PARP1 P09874 1/20 0.52
IDO1 P14902 2/20 0.51
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 1/20 0.51
EPHX2 P34913 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1395822 1.00 HTR3E (0.67) HTR3EHTR3BHTR3AHTR3DHTR3C
Hydrochloric Acid SCHEMBL2175078 0.98 HTR3E (0.65) HTR3EHTR3BHTR3AHTR3DHTR3C
Trifluoroacetic Acid SCHEMBL6379095 0.88 HTR3E (0.54) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL10339219 0.85 CA2 (0.54) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL11172110 0.83 CTBP2 (0.62) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL1350536 0.82 CTBP2 (0.61) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL467923 0.82 CTBP2 (0.66) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL3876977 0.81 ALDH1A1 (0.58) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL30687017 0.81 FFAR1 (0.50) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL24831479 0.81 HTR3E (0.58) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023069721-A2 OXAZOLE, OXADIAZOLE, AND INDOLE DERIVATIVES FOR THE INHIBITION OF USP28 CARMOT THERAPEUTICS, INC. (US) 2023-04-27 WO disclosed